03/05/2023 Eli Lilly announces positive top-line results from the TRAILBLAZER-ALZ2 trial of donanemab Science watch
01/05/2023 Alnylam and Regeneron report positive interim results from their Phase 1 trial of ALN-APP in patients with early-onset Alzheimer’s disease Science watch
19/04/2023 The cost-of-living crisis has exacerbated inequalities in access and use of dementia care in the UK Science watch
13/04/2023 Timely use of hearing aids may reduce the risk of dementia in people with hearing difficulties, according to UK Biobank study Science watch
06/04/2023 American health economics study reveals the cost-effectiveness of non-pharmacological interventions for people with dementia and their caregivers Science watch
30/03/2023 Anavex announces findings from an extended study of ANAVEX2-73 in Parkinson’s disease dementia Science watch
29/03/2023 Biogen presents Phase Ib data showing reduction of tau protein levels in people with mild AD Science watch
26/03/2023 Post-hoc analysis of 3-year data from the LipiDiDiet clinical trial reveals slower clinical decline in participants receiving a multinutrient supplement Science watch
22/03/2023 Roche announces collaboration with Lilly to enhance early diagnosis of Alzheimer's disease Science watch
21/03/2023 Analysis of Rotterdam study shows that people with low bone mineral density may have a higher risk of developing dementia Science watch
